The best of EcoWatch, right in your inbox. Sign up for our email newsletter!
In Blow to Monsanto, India's Top Court Upholds Decision That Seeds Cannot Be Patented
In an another legal blow to Monsanto, India's Supreme Court on Monday refused to stay the Delhi High Court's ruling that the seed giant cannot claim patents for Bollgard and Bollgard II, its genetically modified cotton seeds, in the country.
Monsanto's chief technology officer Robert Fraley, who just announced that he and other top executives are stepping down from the company after Bayer AG's multi-billion dollar takeover closes, lamented the news.
Fraley tweeted, "Having personally helped to launch Bollgard cotton in India & knowing how it has benefited farmers ... it's sad to see the country go down an anti-science/anti-IP/anti-innovation path..."
Monsanto first introduced its GM-technology in India in 1995. Today, more than 90 percent of the country's cotton crop is genetically modified. These crops have been inserted with a pest-resistant toxin called Bacillus thuringiensis, or Bt.
Citing India's Patents Act of 1970, the Delhi High Court ruled last month that plant varieties and seeds cannot be patented, thereby rejecting Monsanto's attempt to block its Indian licensee, Nuziveedu Seeds Ltd., from selling the seeds.
Because of the ruling, Monsanto's claims against Nuziveedu for unpaid royalties have been waived, as its patents are now invalid under Indian law. Royalties will now be decided by the government.
Indian environmentalist Vandana Shiva, who is known for her fierce activism against corporate patents on seeds, called the top court's move a "major victory" that opens the door "to make Monsanto pay for trapping farmers in debt by extracting illegal royalties on BT cotton."
She also said in a video Monday in front of the Supreme Court, "Our sovereignty is protected, our laws are protected. Our ability to write laws in the public interest [and] for the rights of farmers through the constitution are protected."
"The Earth will win. Seed will win. Monsanto will lose," Shiva added.
A Monsanto India spokesman told Reuters the case will be submitted for an expedited preliminary hearing on July 18.
"We remain confident on the merits of the case. India has been issuing patents on man-made biotech products for more than 15 years, as is done widely across the globe," the spokesman said.
- GM cotton's return to Burkina Faso on hold over Bayer-Monsanto deal ›
- Bayer-Monsanto merger gets a green light, but farmers are worried ... ›
- The Seeds Of Suicide: How Monsanto Destroys Farming | Global ... ›
EcoWatch Daily Newsletter
Low-Fat Diets Rich in Fruits and Veggies May Reduce Women’s Risk of Breast Cancer Death, Study Finds
Colorado senator and 2020 hopeful Michael Bennet introduced his plan to combat climate change Monday, in the first major policy rollout of his campaign. Bennet's plan calls for the establishment of a "Climate Bank," using $1 trillion in federal spending to "catalyze" $10 trillion in private spending for the U.S. to transition entirely to net-zero emissions by 2050.
When Trump's Environmental Protection Agency (EPA) announced its replacement for the Obama-era Clean Power Plan in August 2018, its own estimates said the reduced regulations could lead to 1,400 early deaths a year from air pollution by 2030.
Now, the EPA wants to change the way it calculates the risks posed by particulate matter pollution, using a model that would lower the death toll from the new plan, The New York Times reported Monday. Five current or former EPA officials familiar with the plan told The Times that the new method would assume there is no significant health gain by lowering air pollution levels below the legal limit. However, many public health experts say that there is no safe level of particulate matter exposure, which has long been linked to heart and lung disease.
By Andrea Germanos
Animal welfare advocates are praising soon-to-be introduced legislation in the U.S. that would ban the use of wild animals in traveling circuses.